Open AccessPS1577 PLATELET COUNT AND MEAN PLATELET VOLUME IN ACUTE STROKE: A SYSTEMATIC REVIEW AND META‐ANALYSIS
Author(s) -
Shemirani H.A.,
Sadeghi F.,
Kovács S.,
Zsóri K.S.,
Bereczky Z.,
csiki Z.
Publication year - 2019
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000564556.92986.0e
Subject(s) - medicine , strictly standardized mean difference , meta analysis , stroke (engine) , confidence interval , mean platelet volume , inclusion and exclusion criteria , subgroup analysis , platelet , pathology , alternative medicine , mechanical engineering , engineering
Background: Changes of platelet count (PC) and mean platelet volume (MPV) could be a marker or a predictor of acute stroke (AS). Aims: We conducted a systematic review and meta‐analysis of the published literature on the reporting of MPV and PC in AS. Methods: Medline, EBSCOhost, Web of Science, ScienceDirect, Google Scholar and Scopus were searched for studies. Studies were included in accordance with Patient Population or Problem, Intervention, Comparison, Outcomes, and Setting (PICOS) framework. The PRISMA strategy was used to report findings. Risk of bias was assessed with Newcastle‐Ottawa Scale. The inclusion criteria were case‐control or cross‐sectional studies, individuals suffered an acute stroke, with fatal or non‐fatal stroke outcomes. Standardized mean difference (SMD) was calculated with a confidence interval of 95% (95% CI). Results: We included 32 eligible articles retrieved from the literature. PC was significantly lower in AS patients [standardized mean difference (SMD) = 0.30, (95%CI: 0.49–0.11), N = 2492, P = 0.002] compared with controls (N = 3615). The MPV was significantly higher [SMD = 0.51, (95%CI: 0.27–0.74), N = 2413, P < 0.001] compared with controls (N = 3621). Subgroup analyses showed significantly lower PC in both ischemic stroke (Difference SMD = 0.18, 95%CI: 0.35‐0.01) and hemorrhagic stroke (0.94, 1.62–0.25), but only samples by citrate anticoagulant showed significantly lower result for patients compared to controls (0.36, 0.68–0.04). Ischemic stroke patients had higher MPV (0.55, 0.29–0.81), and samples by EDTA anticoagulant showed significantly higher result for patients compared to controls (0.79, 0.49–1.10). Summary/Conclusion: PC and MPV appeared to be significantly different between patients with AS and control populations. MPV was significantly higher in ischemic stroke and PC was significantly lower in both ischemic and hemorrhagic strokes. It is advisable to pay attention to the type of anticoagulant for hematology analyses in AS. Our results highlight the potential predictive role of PC and MPV in the occurrence of stroke.